CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 80 filers reported holding CYMABAY THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $17,188,416 | +22.4% | 727,706 | -22.7% | 0.00% | 0.0% |
Q3 2023 | $14,042,357 | +39.1% | 941,808 | +2.1% | 0.00% | +33.3% |
Q2 2023 | $10,096,108 | +21.3% | 922,019 | -3.4% | 0.00% | +50.0% |
Q1 2023 | $8,324,348 | +854.2% | 954,627 | +586.1% | 0.00% | – |
Q4 2022 | $872,364 | +47.9% | 139,133 | -17.5% | 0.00% | – |
Q3 2022 | $590,000 | -11.1% | 168,694 | -25.1% | 0.00% | – |
Q2 2022 | $664,000 | -4.0% | 225,254 | +1.2% | 0.00% | – |
Q1 2022 | $692,000 | -21.6% | 222,495 | -14.8% | 0.00% | – |
Q4 2021 | $883,000 | -6.5% | 261,207 | +1.0% | 0.00% | – |
Q3 2021 | $944,000 | -9.1% | 258,590 | +8.6% | 0.00% | – |
Q2 2021 | $1,038,000 | +1.7% | 238,108 | +5.8% | 0.00% | – |
Q1 2021 | $1,021,000 | -17.8% | 225,072 | +4.0% | 0.00% | – |
Q4 2020 | $1,242,000 | -90.9% | 216,407 | -88.5% | 0.00% | -100.0% |
Q3 2020 | $13,594,000 | +3970.1% | 1,877,586 | +1861.4% | 0.01% | – |
Q2 2020 | $334,000 | +114.1% | 95,728 | -9.4% | 0.00% | – |
Q1 2020 | $156,000 | -84.3% | 105,614 | -45.4% | 0.00% | – |
Q3 2019 | $991,000 | -10.8% | 193,575 | +24.7% | 0.00% | – |
Q2 2019 | $1,111,000 | -86.3% | 155,211 | -78.8% | 0.00% | -100.0% |
Q3 2018 | $8,122,000 | +71.7% | 733,003 | +107.9% | 0.00% | +50.0% |
Q2 2018 | $4,731,000 | +50.2% | 352,522 | +45.4% | 0.00% | +100.0% |
Q1 2018 | $3,150,000 | +55.2% | 242,526 | +9.9% | 0.00% | 0.0% |
Q4 2017 | $2,030,000 | – | 220,660 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 1,787,094 | $26,645,572 | 14.80% |
Lynx1 Capital Management LP | 994,161 | $14,822,941 | 9.80% |
Octagon Capital Advisors LP | 3,073,750 | $45,829,613 | 7.04% |
Saturn V Capital Management LP | 1,124,459 | $16,765,684 | 7.02% |
Altium Capital Management LP | 800,000 | $11,928,000 | 6.22% |
Affinity Asset Advisors, LLC | 1,129,376 | $16,838,996 | 4.74% |
ACUTA CAPITAL PARTNERS, LLC | 418,000 | $6,232,380 | 4.18% |
Cormorant Asset Management, LP | 3,850,000 | $57,403,500 | 3.35% |
SILVERARC CAPITAL MANAGEMENT, LLC | 590,000 | $8,796,900 | 2.67% |
MPM BioImpact LLC | 610,770 | $9,106,581 | 2.43% |